Memantine and prevention of worsening in functional communication: post hoc analysis of a randomized, placebo-controlled trial in patients with moderate Alzheimer's disease

被引：0
|
作者：
Graham, S. M. [1 ]
Tocco, M. [1 ]
Hendrix, S. [2 ]
Hofbauer, R. K. [1 ]
Perhach, J. L. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Pentara Corp, Salt Lake City, UT USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of memantine in patients with mild to moderate vascular dementia -: A randomized, placebo-controlled trial (MMM 300)
    Orgogozo, JM
    Rigaud, AS
    Stöffler, A
    Möbius, HJ
    Forette, F
    STROKE, 2002, 33 (07) : 1834 - 1839
  • [32] Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
    Wilkinson, David
    Andersen, Henning Friis
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (02) : 138 - 145
  • [33] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S207
  • [34] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: randomized, controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    ANNALS OF NEUROLOGY, 2004, 56 : S49 - S49
  • [35] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S332 - S332
  • [36] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, E. R.
    Potkin, S. G.
    Pomara, N.
    Ott, B. R.
    McDonald, S.
    Xie, Y.
    Gergel, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 187 - 187
  • [37] Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
    Tariot, PN
    Farlow, MR
    Grossberg, GT
    Graham, SM
    McDonald, S
    Gergel, I
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03): : 317 - 324
  • [38] Memantine, monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Pomara, N
    Peskind, ER
    Potkin, SG
    McDonald, S
    Xie, Y
    Gergel, I
    NEUROBIOLOGY OF AGING, 2004, 25 : S19 - S19
  • [39] A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease
    van Dyck, Christopher H.
    Tariot, Pierre N.
    Meyers, Barnett
    Resnick, E. Malca
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (02): : 136 - 143
  • [40] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
    Nakamura, Yu
    Kitamura, Shin
    Homma, Akira
    Shiosakai, Kazuhito
    Matsui, Daiju
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925
12345